v3.26.1
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Operating activities        
Net income (loss) attributable to ordinary shareholders $ 176 $ (1,873) $ 198 $ (2,012)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:        
Share-based compensation     127 178
Realized gain on other investments (35)
SurancePlus management fee income (501) (1) (501) (1)
Depreciation and amortization     2
Change in fair value of other investments 20
Change in fair value of equity securities 12 9
Income (loss) attributable to non-controlling interests 116 (131) 132 (117)
Change in operating assets and liabilities:        
Operating right-of-use asset     (70) 52
Operating lease liabilities     70 (52)
Premiums receivable     459 (918)
Deferred policy acquisition costs     67 (115)
Prepayment and other assets     18 (23)
Reserve for loss and loss adjustment expenses     175
Premium payable     31
Unearned premiums reserve     (610) 1,046
Accounts payable and other liabilities     20 (106)
Net cash used in operating activities     (57) (1,899)
Investing activities        
Proceeds from sale of other investments     63
Net cash provided by investing activities     63
Financing activities        
Proceeds from issuance (redemption) of Tokenholders     40 (526)
Proceeds from issuance of ordinary shares     342 3,122
Proceeds from issuance of HCI 2026 Series A, B & C Tokens     6,323
Proceeds from HCI Additional Collateral Deposit     6,198
Net cash provided by financing activities     12,903 2,596
Cash and cash equivalents, and restricted cash and cash equivalents:        
Net change during the period     12,846 760
Balance at beginning of period     6,976 5,893
Balance at end of period $ 19,822 $ 6,653 19,822 6,653
Non-cash investing and financing activities        
Right-of-use lease asset obtained in exchange for operating lease liabilities     89
Reclassification of contributed non-controlling interest     3 104
Reclassification of other liabilities EpsilonCat Re / DeltaCat Re     $ 1,732